Interim data from the ongoing EPITOME trial1 showed that 45.7% of stroke survivors with paresis developed post-stroke spasticity within 1 year<1% of stroke survivors receive BoNT-A treatment for ...

The two mainstays of nonpharmacological spasticity management are the removal of noxious stimuli that can drive hypertonicity and the application of physical modalities. Comorbidities of neurological ...

Spasticity is a condition that causes muscle stiffness and affects a person’s ability to speak and move. A variety of different treatment options are available to help manage this condition.

Spasticity is a clinical sign characterized by muscle over-activity and high tone spasms that is associated with several distinct neurological diseases. Timely diagnosis and management are essential ...

Being diagnosed with multiple sclerosis can, naturally, have an enormous impact on your life. You may need to make some lifestyle changes and try a few treatments to help manage the various symptoms, ...